HCP
TMO icon

Hexagon Capital Partners’s Thermo Fisher Scientific TMO Stock Holding History

Hexagon Capital Partners’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$232K Buy
+472
New +$256K 0.03% 226
2025
Q2 		– Sell
-521
Closed -$259K – 1561
2025
Q1 		$259K Sell
521
-129
-20% -$69.9K 0.05% 178
2024
Q4 		$338K Buy
650
+151
+30% +$83K 0.06% 139
2024
Q3 		$309K Sell
499
-14
-3% -$8.29K 0.06% 150
2024
Q2 		$284K Buy
513
+3
+0.6% +$1.72K 0.06% 154
2024
Q1 		$296K Sell
510
-45
-8% -$25.3K 0.07% 149
2023
Q4 		$295K Buy
555
+6
+1% +$2.9K 0.07% 143
2023
Q3 		$278K Sell
549
-9
-2% -$4.8K 0.07% 128
2023
Q2 		$291K Sell
558
-34
-6% -$18.3K 0.08% 124
2023
Q1 		$341K Sell
592
-1
-0.2% -$564 0.1% 105
2022
Q4 		$327K Sell
593
-111
-16% -$58.8K 0.1% 107
2022
Q3 		$357K Sell
704
-42
-6% -$23.5K 0.11% 101
2022
Q2 		$405K Buy
746
+91
+14% +$50.1K 0.12% 101
2022
Q1 		$387K Sell
655
-12
-2% -$6.89K 0.1% 115
2021
Q4 		$445K Sell
667
-22
-3% -$13.7K 0.12% 101
2021
Q3 		$394K Sell
689
-29
-4% -$15.9K 0.11% 97
2021
Q2 		$362K Sell
718
-46
-6% -$21.7K 0.1% 103
2021
Q1 		$348K Sell
764
-263
-26% -$126K 0.1% 96
2020
Q4 		$478K Buy
1,027
+68
+7% +$31.9K 0.14% 65
2020
Q3 		$460K Buy
+959
New +$396K 0.15% 66

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Hexagon Capital Partners's TMO Position: Q1 2026 in Review

Hexagon Capital Partners opened a new position in Thermo Fisher Scientific (TMO) in Q1 2026: 472 shares worth $232K. The stake represents 0.03% of the portfolio and ranks #226 among its holdings. This is a return to the name: Hexagon Capital Partners previously reported a position in TMO as recently as Q1 2025.

Hexagon Capital Partners first reported a position in TMO in Q3 2020 and has held it in 20 quarters since. The position peaked at $478K in Q4 2020. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Hexagon Capital Partners held 472 shares of Thermo Fisher Scientific worth $232K as of Q1 2026.
  • Thermo Fisher Scientific was a new Hexagon Capital Partners position in Q1 2026.
  • Thermo Fisher Scientific made up 0.03% of Hexagon Capital Partners's portfolio in Q1 2026, its #226 holding.
  • Hexagon Capital Partners first reported a position in Thermo Fisher Scientific in Q3 2020 and has held it in 20 quarters since.
  • Hexagon Capital Partners's Thermo Fisher Scientific position peaked at $478K in Q4 2020.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Hexagon Capital Partners's 13F filing for Q1 2026, filed 5 May 2026.